Skip to content

Elamipretide (SS-31) studies: 372 papers with results

Page 4 of 8

  1. Mitochondrial antioxidant elamipretide improves learning and memory impairment induced by chronic sleep deprivation in mice.

    Zhang YM · Brain and behavior · 2024

    Animal study (in vivo) · mouse · 10 results

  2. Age-related changes of skeletal muscle metabolic response to contraction are also sex-dependent.

    Campbell MD · The Journal of physiology · 2025

    Animal study (in vivo) · mouse · 2 results

  3. Targeting mitochondrial stress with Szeto-Schiller 31 prevents experimental abdominal aortic aneurysm: Crosstalk with endoplasmic reticulum stress.

    Navas-Madroñal M · British journal of pharmacology · 2023

    Animal study (in vivo) · mouse · 11 results

  4. Synovial fluid mitochondrial DNA concentration reflects the degree of cartilage damage after naturally occurring articular injury.

    Seewald LA · Osteoarthritis and cartilage · 2023

    Animal study (in vivo) · equine · 1 result

  5. Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury.

    Wyss JC · Frontiers in pharmacology · 2019

    Animal study (in vivo) · mouse · 5 results

  6. Anti-VEGFR2 F(ab')2 drug conjugate promotes renal accumulation and glomerular repair in diabetic nephropathy.

    Liu D · Nature communications · 2023

    Animal study (in vivo) · mouse · 1 result

  7. The mitochondria-targeted small molecule SS31 delays progression of behavioral deficits by attenuating β-amyloid plaque formation and mitochondrial/synaptic deterioration in APP/PS1 mice.

    Jia YL · Biochemical and biophysical research communications · 2023

    Animal study (in vivo) · mouse · 7 results

  8. Treatment of age-related visual impairment with a peptide acting on mitochondria.

    Alam NM · Disease models & mechanisms · 2022

    Animal study (in vivo) · mouse · 8 results

  9. SS-31 efficacy in a mouse model of Friedreich ataxia by upregulation of frataxin expression.

    Liu Y · Human molecular genetics · 2021

    Animal study (in vivo) · mouse · 10 results

  10. Hypochlorite modified albumins promote cell death in the tubule interstitium in rats via mitochondrial damage in obstructive nephropathy and the protective effects of antioxidant peptides.

    Liu ZR · Free radical research · 2018

    Animal study (in vivo) · rat · 4 results

  11. Hepatocyte mitochondrial DNA mediates macrophage immune response in liver injury induced by trichloroethylene.

    Gao L · Ecotoxicology and environmental safety · 2024

    Animal study (in vivo) · mouse · 3 results

  12. Platelet Membrane-Encapsulated MSNs Loaded with SS31 Peptide Alleviate Myocardial Ischemia-Reperfusion Injury.

    Zhang Z · Journal of functional biomaterials · 2022

    Animal study (in vivo) · 3 results

  13. Experimental coronary artery stenosis accelerates kidney damage in renovascular hypertensive swine.

    Sun D · Kidney international · 2015

    Animal study (in vivo) · pig · 3 results

  14. Targeting mitochondria in the aged cerebral vasculature with SS-31, a proteomic study of brain microvessels.

    Seman A · GeroScience · 2023

    Animal study (in vivo) · mouse · 4 results

  15. SS31 Confers Cerebral Protection by Reversing Mitochondrial Dysfunction in Early Brain Injury Following Subarachnoid Hemorrhage, via the Nrf2- and PGC-1α-Dependent Pathways.

    Zhou J · Neurochemical research · 2023

    Animal study (in vivo) · 12 results

  16. Elamipretide treatment during pregnancy ameliorates the progression of polycystic kidney disease in maternal and neonatal mice with PKD1 mutations.

    Daneshgar N · Kidney international · 2022

    Animal study (in vivo) · mouse · 6 results

  17. Adverse Neurological Effects of Short-Term Sleep Deprivation in Aging Mice Are Prevented by SS31 Peptide.

    Wu J · Clocks & sleep · 2020

    Animal study (in vivo) · mouse · 5 results

  18. Mitochondrial targeted therapy with elamipretide (MTP-131) as an adjunct to tumor necrosis factor inhibition for traumatic optic neuropathy in the acute setting.

    Tse BC · Experimental eye research · 2020

    Animal study (in vivo) · mouse · 4 results

  19. In vivo high-resolution magic angle spinning magnetic and electron paramagnetic resonance spectroscopic analysis of mitochondria-targeted peptide in Drosophila melanogaster with trauma-induced thoracic injury.

    Constantinou C · International journal of molecular medicine · 2016

    Animal study (in vivo) · drosophila melanogaster · 2 results

  20. Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening.

    Patai R · GeroScience · 2025

    Animal study (in vivo) · mouse · 1 result

  21. Long-term treatment with Elamipretide enhances healthy aging phenotypes in mice.

    Nickel K · Aging pathobiology and therapeutics · 2022

    Animal study (in vivo) · mouse · 6 results

  22. SS31 alleviates LPS-induced acute lung injury by inhibiting inflammatory responses through the S100A8/NLRP3/GSDMD signaling pathway.

    Luo P · European journal of medical research · 2024

    Animal study (in vivo) · mouse · 8 results

  23. Skeletal muscle mitochondrial dysfunction mediated by Pseudomonas aeruginosa quorum-sensing transcription factor MvfR: reversing effects with anti-MvfR and mitochondrial-targeted compounds.

    Aggarwal S · mBio · 2024

    Animal study (in vivo) · mouse · 1 result

  24. Mitochondria-targeted reactive oxygen species blockor SS-31 blocks hepatic stellate cell activation and alleviates hepatic fibrosis by regulating NLRP3 inflammasomes.

    Liu L · Cellular and molecular biology (Noisy-le-Grand, France) · 2024

    Animal study (in vivo) · mouse · 10 results

  25. Elamipretide effects on the skeletal muscle phosphoproteome in aged female mice.

    Campbell MD · GeroScience · 2022

    Animal study (in vivo) · mouse · 1 result

  26. SS-31 ameliorates hepatic injury in rats subjected to severe burns plus delayed resuscitation via inhibiting the mtDNA/STING pathway in Kupffer cells.

    Wu Y · Biochemical and biophysical research communications · 2021

    Animal study (in vivo) · rat · 6 results

  27. [Protective effect of mitochondria-targeted antioxidant peptide SS-31 in sepsis-induced acute kidney injury].

    Sun M · Zhonghua wei zhong bing ji jiu yi xue · 2021

    Animal study (in vivo) · mouse · 7 results

  28. Early treatment with combination of SS31 and entresto effectively preserved the heart function in doxorubicin-induced dilated cardiomyopathic rat.

    Yeh JN · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021

    Animal study (in vivo) · rat · 9 results

  29. Arsenic Directs Stem Cell Fate by Imparting Notch Signaling Into the Extracellular Matrix Niche.

    Anguiano T · Toxicological sciences : an official journal of the Society of Toxicology · 2020

    Animal study (in vivo) · mouse · 3 results

  30. Protective effect of the antioxidative peptide SS31 on ionizing radiation-induced hematopoietic system damage in mice.

    Han X · Blood cells, molecules & diseases · 2019

    Animal study (in vivo) · mouse · 9 results

  31. Mitochondrial Cardiolipin-Targeted Tetrapeptide, SS-31, Exerts Neuroprotective Effects Within In Vitro and In Vivo Models of Spinal Cord Injury.

    Ravenscraft B · International journal of molecular sciences · 2025

    Animal study (in vivo) · mouse · 6 results

  32. Role of AQP3 in the Vascular Leakage of Sepsis and the Protective Effect of Ss-31.

    Zhang J · Journal of cardiovascular pharmacology · 2021

    Animal study (in vivo) · rat · 4 results

  33. Effects of Elamipretide on Autophagy in Renal Cells of Pigs with Metabolic Syndrome.

    Hong S · Cells · 2022

    Animal study (in vivo) · pig · 5 results

  34. SS31 Ameliorates Oxidative Stress via the Restoration of Autophagic Flux to Protect Aged Mice From Hind Limb Ischemia.

    Yang Q · Frontiers in cardiovascular medicine · 2022

    Animal study (in vivo) · mouse · 11 results

  35. A 50 kdyne contusion spinal cord injury with or without the drug SS-31 was not associated with major changes in muscle mass or gene expression 14 d after injury in young male mice.

    Graham ZA · Physiological reports · 2021

    Animal study (in vivo) · mouse · 5 results

  36. A mitochondrial targeting tetrapeptide Bendavia protects lateral line hair cells from gentamicin exposure.

    Kuang X · Journal of applied toxicology : JAT · 2018

    Animal study (in vivo) · zebrafish · 3 results

  37. YTHDF1-mediated mitochondrial dysfunction and allergic airway inflammation by interaction with β-catenin/TCF4 signaling.

    Xie C · International immunopharmacology · 2025

    Animal study (in vivo) · mouse · 2 results

  38. Intermittent treatment with elamipretide preserves exercise tolerance in aged female mice.

    Campbell MD · GeroScience · 2023

    Animal study (in vivo) · mouse · 5 results

  39. Aging Increases Susceptibility to Develop Cardiac Hypertrophy following High Sugar Consumption.

    Valencia AP · Nutrients · 2022

    Animal study (in vivo) · mouse · 3 results

  40. Mitochondrial dysfunction drives age-related degeneration of the thoracic aorta.

    Dhanekula AS · GeroScience · 2026

    Animal study (in vivo) · mouse · 5 results

  41. SS-31 improves post-cardiac arrest brain injury by inhibiting microglial ferroptosis and polarization.

    Jiang T · Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026

    Animal study (in vivo) · rat · 11 results

  42. Acute mitochondrial reactive oxygen species emissions drive mitochondrial dysfunction after traumatic muscle injury in male mice.

    Heo J · American journal of physiology. Cell physiology · 2025

    Animal study (in vivo) · mouse · 6 results

  43. Mitochondrial Targeting by Elamipretide Improves Myocardial Bioenergetics Without Translating into Functional Benefits in HFpEF.

    Schauer A · International journal of molecular sciences · 2026

    Animal study (in vivo) · rat · 15 results

  44. Elamipretide Improves Mitochondrial Function in Mitochondrial Trifunctional Protein-Deficient Mice and Human Fibroblasts.

    Vieira Neto E · Journal of inherited metabolic disease · 2026

    Animal study (in vivo) · mouse · 7 results

  45. SS-31: A promising therapeutic agent against bleomycin-induced pulmonary fibrosis in Mice.

    Gu Q · PloS one · 2025

    Animal study (in vivo) · mouse · 9 results

  46. Protective effects of SS-31 against SDHB suppression-mitochondrial dysfunction-EndMT axis-modulated CBT sclerosis and progression.

    Tang H · American journal of translational research · 2020

    Animal study (in vivo) · mouse · 5 results

  47. Szeto-Schiller 31 eases acute lung injury in neonatal mice with acute respiratory distress syndrome by mediating TXNIP expression and NLRP3 inflammasome activation.

    Zhu M · Translational pediatrics · 2025

    Animal study (in vivo) · mouse · 13 results

  48. [Protective effect of mitochondria-targeted antioxidant SS31 on early brain injury following subarachnoid hemorrhage in rats].

    Zhou J · Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2017

    Animal study (in vivo) · rat · 9 results

  49. Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury.

    Song Z · Neurochemistry international · 2026

    Animal study (in vivo) · mouse · 12 results

  50. Breaking a mitochondrial danger-STING feed-forward amplifier preserves alveolar-capillary architecture and dampens interferon-chemokine signaling in acute lung injury.

    Elmorsy EA · Tissue & cell · 2026

    Animal study (in vivo) · 6 results

How PepBank reports evidence